Tucker Asset Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Tucker Asset Management’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$8.13K	Buy	+1,114	New	+$12.2K	﹤0.01%	615

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

Tucker Asset Management's QNTM Position: Q4 2025 in Review

Tucker Asset Management opened a new position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2025: 1,114 shares worth $8.13K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings.

24 funds tracked by Wall St. Rank hold QNTM as of Q4 2025.

Tucker Asset Management held 1,114 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $8.13K as of Q4 2025.
Quantum Biopharma Class B Subordinate Voting Shares was a new Tucker Asset Management position in Q4 2025.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #615 holding.
24 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.